Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury

NCT02975271 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Business Reasons

Conditions

Pruritus
Burns

Interventions

DRUG: Serlopitant
DRUG: Placebo

Sponsor

Vyne Therapeutics Inc.